Literature DB >> 8412179

Salivary duct carcinoma.

R V Kumar1, L Kini, A K Bhargava, G Mukherjee, D Hazarika, A M Shenoy, N Anantha.   

Abstract

Salivary duct carcinoma is an uncommon malignant tumor that occurs mainly in the parotid gland of elderly men. The 11 cases of salivary duct carcinoma which are included in this study occurred in older men (mean age 56 years) and were located in the parotid (7), submandibular salivary gland (2), and the minor salivary glands in the maxilla (2). The maximum tumor dimension ranged from 3 to 9 cm. Microscopically, all had infiltrating margins, with circumscribed groups of epithelial cells arranged in various patterns; the invasive component was embedded in a desmoplastic stroma. Perineural invasion and lymph node metastasis were noted in seven and three cases, respectively, at the time of initial surgery. Radical surgery was offered to ten patients and postoperative radiotherapy to nine patients. Salivary duct carcinoma appears to be an aggressive tumor with distinctive histological features, which has not been described in the minor salivary glands of the maxilla to date. The clinicopathologic features of these tumors are presented, with a review of the literature.

Entities:  

Mesh:

Year:  1993        PMID: 8412179     DOI: 10.1002/jso.2930540315

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

Review 1.  [Salivary duct carcinoma].

Authors:  D Hungermann; K Roeser; H Buerger; T Jäkel; T Löning; H Herbst
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

Review 2.  Mucin-rich salivary duct carcinoma with signet-ring cell feature ex pleomorphic adenoma of the submandibular gland: a case report of an unusual histology with immunohistochemical analysis and review of the literature.

Authors:  Kimihide Kusafuka; Matsuyoshi Maeda; Masatake Honda; Takashi Nakajima
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

3.  Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.

Authors:  Vijayvel Jayaprakash; Mihai Merzianu; Graham W Warren; Hassan Arshad; Wesley L Hicks; Nestor R Rigual; Maureen A Sullivan; Mukund Seshadri; James R Marshall; David M Cohan; Yujie Zhao; Anurag K Singh
Journal:  Head Neck       Date:  2013-10-07       Impact factor: 3.147

Review 4.  Submandibular gland metastasis of breast carcinoma: a case report and review of the literature.

Authors:  G Vessecchia; S Di Palma; R Giardini
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.

Authors:  Takeshi Imai; Kensuke Shinohara; Kenji Uchino; Hirohisa Okuma; Futaba Maki; Kiyoshi Hiruma; Yasushi Ariizumi; Yoshihisa Yamano
Journal:  BMC Neurol       Date:  2022-05-02       Impact factor: 2.903

6.  Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma.

Authors:  Sebastian Adeberg; Paul Windisch; Felix Ehret; Melissa Baur; Sati Akbaba; Thomas Held; Denise Bernhardt; Matthias F Haefner; Juergen Krauss; Steffen Kargus; Christian Freudlsperger; Peter Plinkert; Christa Flechtenmacher; Klaus Herfarth; Juergen Debus; Stefan Rieken
Journal:  Front Oncol       Date:  2019-12-20       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.